Gigasolar Materials Corp (3691) – Power – Deals and Alliances Profile

Gigasolar Materials Corp (3691) – Power – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

Gigasolar Materials Corp (Giga Solar), formerly Gigastorage optoelectronic materials is a solar products manufacturing company that manufactures and markets solar conductive pastes. The company’s products include solar cell backside aluminium paste, solar cell front side silver paste, and solar cell backside silver paste. Its front side silver paste finds applications in producing cell electrodes. Giga Solar also offers solar conductive paste that includes organic chemistry, mechanical and electrical science, inorganic materials, high-temperature sintering, fine line printing, and chemical reactions. The company connects with upstream and downstream solar energy industries. Giga Solar is headquartered in Hsinchu, Taiwan.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Energy and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345177

Fresenius Kidney Care – Medical Equipment – Deals and Alliances Profile

Fresenius Kidney Care – Medical Equipment – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

Fresenius Kidney Care (FMCNA) , formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical information system, bloodlines and concentrates, home therapy products and others; its home therapy products include peritoneal dialysis products and home hemodialysis products. FMCNA offers services such as patient care, laboratory services, customer and technical support, courier services, education and training, managed care, billing, physician services, inpatient services and research services. The company has presence in Utah, and Walnut Creek, Ogden, California. FMCNA is headquartered in Waltham, Massachusetts, the US.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Medical Devices and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345176

Cosmo Pharmaceuticals NV (COPN) – Medical Equipment – Deals and Alliances Profile

Cosmo Pharmaceuticals NV (COPN) – Medical Equipment – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

Cosmo Pharmaceuticals NV (Cosmo) is a pharmaceutical company that develops drugs for the treatment of gastro-intestinal diseases. The company develops its pharmaceutical products based on its multi matrix (MMX) technology. Its proprietary clinical development pipeline intended for the treatment of various gastro-intestinal tract, inflammatory bowel diseases, colon infections and colon diagnosis. Cosmo also offers SIC 8000, a submucosal injectable composition for extracting polyps and adenomas; and other products. The company manufactures products for oral administration such as tablets, capsules, powders and syrups; topical dosage forms such as emulsions, gels, ointments and others; and injectables. Its manufacturing facility is located in Lainate, Milan. Cosmo is headquartered in Dublin, Ireland.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Medical Devices and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345175

Avalign Technologies Inc – Medical Equipment – Deals and Alliances Profile

Avalign Technologies Inc – Medical Equipment – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

Avalign Technologies Inc (Avalign), a subsidiary of Arlington Capital Partners LP is a medical device company that offers cutting instruments. The company offers cutting instruments, cases and trays, german instruments and instruments and implant products. It manufactures instruments and implants through CNC mills, citizen swiss turning centers, mill turns, wire EDMs, gun drills, coordinate measuring machines, OGP vision measurement system and ultrasonic cleaning technologies. The company also offers research and development; design, prototyping, testing and production programs. It operates in Lake Forest, Warsaw, Greenwood, Fort Wayne, Schaumburg and Tuttlingen. Avalign is headquartered in Lake Forest, Illinois, the US.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Medical Devices and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345174

Rebiotix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Rebiotix Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that offers treatment solutions for debilitating diseases by harnessing the power of the human microbiome. The company harnesses microbiota restoration therapy, a drug delivery platform that releases healthy, live and human-derived microbes into the intestinal tract of a patient to treat diseases. The company’s lead product, RBX2660 is a non-antibiotic therapy that is used to treat clostridium difficile infection. It also develops therapies for ulcerative colitis, hepatic encephalopathy and multi-drug resistant organisms. Rebiotix is headquartered in Roseville, Minnesota, the US.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Life Sciences and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345195

SR One Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

SR One Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

News5050 – Company Reports

December 21, 2017

The Report:

SR One Ltd (SR One), a subsidiary of GlaxoSmithKline Plc is a venture capital firm that offers investment services for seed, start up, early and mid venture; and emerging growth companies. The firm invests globally in emerging life science companies that are pursuing innovative science which significantly impacts medical care with products in preclinical development stage through clinical proof-of-concept; biotechnology; healthcare; medical devices, and related information technologies companies. It operates through its investment teams located in the US and the UK. The firm has operations in Cambridge, Conshohocken, London and San Francisco. SR One is headquartered in Conshohocken, Pennsylvania, the US.

Scope

– Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
– Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
– Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
– Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
– Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
– Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
– Business Description – A brief description of the company’s operations.
– Key Employees – A list of the key executives of the company.
– Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
– Key Competitors – A list of the key competitors of the company.
– Key Recent Developments – A brief on recent news about the company.

About Research and Experts:

Research and Experts brings you to the latest reports in market research on Life Sciences and much more.

Contact:

John Caldwell

Fia Rua, Deerpark

Bunratty, Co. Clare, Ireland

Check out Market Reports at www.researchandexperts.com

News5050 - ResearchandExperts


Report: REP000345184